Prediction of Key Candidate Genes for Platinum Resistance in Ovarian Cancer

References

• Al Habyan S, Kalos C, Szymborski J, et al. Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer. Oncogene. 2018;37(37):5127–5135. doi:10.1038/s41388-018-0317-x
   PubMed Web of Science ®Google Scholar
• Fitzmaurice C, Allen C, Barber RM, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3(4):524–548. doi:10.1001/jamaoncol.2016.5688
   PubMed Web of Science ®Google Scholar
• Mikuła-Pietrasik J, Witucka A, Pakuła M, et al. Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells. Cell Mol Life Sci. 2019;76(4):681–697. doi:10.1007/s00018-018-2954-1
   PubMed Web of Science ®Google Scholar
• Cervantes-Badillo MG, Paredes-Villa A, Gómez-Romero V, et al. IFI27/ISG12 downregulates estrogen receptor alpha transactivation by facilitating its interaction with CRM1/XPO1 in breast cancer cells. Front Endocrinol. 2020;11:568375. doi:10.3389/fendo.2020.568375
   PubMed Web of Science ®Google Scholar
• Hsieh WL, Huang YH, Wang TM, et al. IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes. Cell Prolif. 2015;48(2):187–197. doi:10.1111/cpr.12168
   PubMed Web of Science ®Google Scholar
• Chiang K-C, Huang S-T, Wu R-C, et al. Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival. Cancer Manag Res. 2019;11:1893–1905. doi:10.2147/CMAR.S196485
   PubMed Web of Science ®Google Scholar
• Rasmussen UB, Wolf C, Mattei MG, et al. Identification of a new interferon-alpha-inducible gene (p27) on human chromosome 14q32 and its expression in breast carcinoma. Cancer Res. 1993;53(17):4096–4101.
   PubMed Web of Science ®Google Scholar
• Pillay K, McCleod H, Chetty R, et al. A study to investigate the role of p27 and cyclin E immunoexpression as a prognostic factor in early breast carcinoma. World J Surg Oncol. 2011;9(1):31. doi:10.1186/1477-7819-9-31
   PubMed Web of Science ®Google Scholar
• Kim SY, Kong WS, Cho JY. Identification of differentially expressed genes in Flammulina velutipes with anti-tyrosinase activity. Curr Microbiol. 2011;62(2):452–457. doi:10.1007/s00284-010-9728-9
   PubMed Web of Science ®Google Scholar
• Li S, Xie Y, Zhang W, et al. Interferon alpha-inducible protein 27 promotes epithelial–mesenchymal transition and induces ovarian tumorigenicity and stemness. J Surg Res. 2015;193(1):255–264. doi:10.1016/j.jss.2014.06.055
   PubMed Web of Science ®Google Scholar
• Budhu A, Chen Y, Kim JW, et al. Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins. Carcinogenesis. 2007;28(7):1552–1560. doi:10.1093/carcin/bgm075
   PubMed Web of Science ®Google Scholar
• Ullah H, Sajid M, Yan K, et al. Antiviral activity of interferon alpha-inducible protein 27 against hepatitis B virus gene expression and replication. Front Microbiol. 2021;12:656353. doi:10.3389/fmicb.2021.656353
   PubMed Web of Science ®Google Scholar
• Shang D, Han T, Xu X, Liu Y. Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-kappaB signaling in human renal clear cell carcinoma. Int J Clin Exp Pathol. 2015;8(9):11140–11148.
   PubMed Web of Science ®Google Scholar
• Lee HR, No HK, Ryu CJ, et al. Brahma-related gene 1-associated expression of 9–27 and IFI-27 is involved in acquired cisplatin resistance of gastric cancer cells. Mol Med Rep. 2013;8(3):747–750. doi:10.3892/mmr.2013.1576
   PubMed Web of Science ®Google Scholar
• Zhang X, Su Y, Wu X, et al. Integrative analysis of the common genetic characteristics in ovarian cancer stem cells sorted by multiple approaches. J Ovarian Res. 2020;13(1):116. doi:10.1186/s13048-020-00715-7
   PubMed Web of Science ®Google Scholar
• Nasr T, Bondock S, Youns M, et al. Synthesis, antitumor evaluation and microarray study of some new pyrazolo[3,4- d][1,2,3]triazine derivatives. Eur J Med Chem. 2017;141:603–614. doi:10.1016/j.ejmech.2017.10.016
   PubMed Web of Science ®Google Scholar
• Kim Y-S, Hwan Do J, Bae S, et al. Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma. BMC Cancer. 2010;10(1):576. doi:10.1186/1471-2407-10-576
   PubMed Web of Science ®Google Scholar
• Xiu MX, Liu YM, Kuang BH. The oncogenic role of Jagged1/Notch signaling in cancer. Biomed Pharmacother. 2020;129:110416. doi:10.1016/j.biopha.2020.110416
   PubMed Web of Science ®Google Scholar
• Li D, Masiero M, Banham AH, Harris AL. The notch ligand JAGGED1 as a target for anti-tumor therapy. Front Oncol. 2014;4:254. doi:10.3389/fonc.2014.00254
   PubMedGoogle Scholar
• Yang J, Xing H, Lu D, et al. Role of Jagged1/STAT 3 signalling in platinum-resistant ovarian cancer. J Cell Mol Med. 2019;23(6):4005–4018. doi:10.1111/jcmm.14286
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhu Y, Li F, et al. GATA1-regulated JAG1 promotes ovarian cancer progression by activating notch signal pathway. Protoplasma. 2020;257(3):901–910. doi:10.1007/s00709-019-01477-w
   PubMed Web of Science ®Google Scholar
• Steg AD, Katre AA, Goodman B, et al. Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer. Clin Cancer Res. 2011;17(17):5674–5685. doi:10.1158/1078-0432.CCR-11-0432
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen C, Guo W, et al. DNM3 attenuates hepatocellular carcinoma growth by activating P53. Med Sci Monit. 2016;22:197–205. doi:10.12659/MSM.896545
   PubMed Web of Science ®Google Scholar
• Reems JA, Wang W, Tsubata K, et al. Dynamin 3 participates in the growth and development of megakaryocytes. Exp Hematol. 2008;36(12):1714–1727. doi:10.1016/j.exphem.2008.08.010
   PubMed Web of Science ®Google Scholar
• Shen J, Wang S, Zhang Y-J, et al. Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology. 2012;55(6):1799–1808. doi:10.1002/hep.25569
   PubMed Web of Science ®Google Scholar
• Gu C, Yao J, Sun P. Dynamin 3 suppresses growth and induces apoptosis of hepatocellular carcinoma cells by activating inducible nitric oxide synthase production. Oncol Lett. 2017;13(6):4776–4784. doi:10.3892/ol.2017.6057
   PubMed Web of Science ®Google Scholar
• Inokawa Y, Nomoto S, Hishida M, et al. Dynamin 3: a new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis. Onco Targets Ther. 2013;6:1417–1424. doi:10.2147/OTT.S51913
   PubMed Web of Science ®Google Scholar